Literature DB >> 11349218

Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis.

H Bayramoğlu1, E Düzcan.   

Abstract

It has been reported that cases of ovarian endometriosis those with epithelial cytological atypia have potential for malignant transformation. This study was planned to determine the incidence of atypical endometriosis and its cytological criteria, to evaluate the malignant potential of atypical endometriosis via immunohistochemical methods (p53). In this study we evaluated 140 samples obtained from 120 cases of ovarian endometriosis and 10 ovarian endometrioid carcinomas that have been previously diagnosed histopathologically. We re-evaluated endometriosis cases with respect to their epithelial and stromal features, existence of acute or chronic inflammatory cells in endometriotic epithelium or stroma and other accompanying histological findings. We observed atypia in 7 (5.8%) cases; reactive atypia in 37 (30.8%) cases, no atypia in 76 (63.4%) cases. We evaluated immunohistochemical p53 expression in 7 atypical cases, 37 reactive atypical cases, and in 10 of those without atypia and in 10 endometrioid carcinoma cases. We noted no staining in cases with atypia, reactive atypia and without atypia while 3 cases of endometrioid carcinoma had positive staining for p53. We concluded that prominent nucleolus and angulation of nuclear contour could be added to criteria of atypia that were mentioned before in the literature. In our study, even though p53 expression could not be shown with immunohistochemical methods in atypical endometriotic cases; it can not be determined that atypical endometriosis lesions are not premalignant. Still, endometriosis cases should be evaluated carefully by the pathologist for foci of cytological atypia and it should be kept in mind that malignant transformation might occur in these atypical endometriosis cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349218     DOI: 10.1007/bf03032602

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

Review 2.  p53 and human malignancies.

Authors:  V Rotter; M Prokocimer
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

3.  An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis.

Authors:  T Haerslev; G K Jacobsen
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

4.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 5.  Malignancy arising in extragonadal endometriosis: a case report and summary of the world literature.

Authors:  J J Brooks; J E Wheeler
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

6.  Adenocarcinoma arising in extragonadal endometriosis: an immunohistochemical study.

Authors:  A C Han; S Hovenden; N G Rosenblum; H Salazar
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

7.  Ovarian carcinoma arising in atypical endometriosis.

Authors:  U M Moll; J C Chumas; E Chalas; W J Mann
Journal:  Obstet Gynecol       Date:  1990-03       Impact factor: 7.661

8.  Histologic transformation of benign endometriosis to early epithelial ovarian cancer.

Authors:  R Sainz de la Cuesta; J H Eichhorn; L W Rice; A F Fuller; N Nikrui; B A Goff
Journal:  Gynecol Oncol       Date:  1996-02       Impact factor: 5.482

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.

Authors:  C Walker; L J Robertson; M W Myskow; N Pendleton; G R Dixon
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more
  9 in total

1.  Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.

Authors:  Tze-Kiong Er; Yu-Fa Su; Chun-Chieh Wu; Chih-Chieh Chen; Jing Wang; Tsung-Hua Hsieh; Marta Herreros-Villanueva; Wan-Tzu Chen; Yi-Ting Chen; Ta-Chih Liu; Hung-Sheng Chen; Eing-Mei Tsai
Journal:  J Mol Med (Berl)       Date:  2016-02-27       Impact factor: 4.599

2.  Integrative Analysis Reveals Regulatory Programs in Endometriosis.

Authors:  Huan Yang; Kai Kang; Chao Cheng; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  Reprod Sci       Date:  2015-06-30       Impact factor: 3.060

3.  Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.

Authors:  Raffaèle Fauvet; Christophe Poncelet; Danièle Hugol; Anne Lavaur; Gérard Feldmann; Emile Daraï
Journal:  Virchows Arch       Date:  2003-05-20       Impact factor: 4.064

Review 4.  Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review).

Authors:  Adriana Ioana Gaia-Oltean; Cornelia Braicu; Diana Gulei; Razvan Ciortea; Dan Mihu; Horace Roman; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

Review 5.  A Systematic Review of Atypical Endometriosis-Associated Biomarkers.

Authors:  Ludovica Bartiromo; Matteo Schimberni; Roberta Villanacci; Giorgia Mangili; Stefano Ferrari; Jessica Ottolina; Noemi Salmeri; Carolina Dolci; Iacopo Tandoi; Massimo Candiani
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

6.  Clinical and Pathological Significance of Cellular Atypia in Endometriosis.

Authors:  Ioana Maria Maier; Adrian Cornel Maier; Andrada Crișan; Lucian Puşcaşiu
Journal:  Medicina (Kaunas)       Date:  2021-05-07       Impact factor: 2.430

7.  Malignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years.

Authors:  Yasuhito Tanase; Naoto Furukawa; Hiroshi Kobayashi; Takashi Matsumoto
Journal:  Case Rep Oncol       Date:  2013-09-21

8.  Long-Term Follow-Up after Surgical Management for Atypical Endometriosis: A Series of Nine Cases.

Authors:  Yasuhito Tanase; Ryuji Kawaguchi; Tomoko Uchiyama; Hiroshi Kobayashi
Journal:  Case Rep Oncol       Date:  2019-01-21

Review 9.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.